Inventor · disambiguated record
John J. Nemunaitis
Also filed as: NEMUNAITIS I JOHN J · NEMUNAITIS JOHN · NEMUNAITIS JOHN J · NEMUNAITIS JOHN JOSEPH
17 granted patents·19 pending applications·90 citations·filing 2006–2025
93Inventor score
Top patents by PatentIndex Score
36 records- 0193US8906874B2Bi-functional shRNA targeting Stathmin 1 and uses thereofRAO DONALD·Filed 2012·Granted Dec 9, 2014·19 cites·33 claims
- 0290US8916530B2Individualized cancer therapySHANAHAN DAVID·Filed 2009·Granted Dec 23, 2014·13 cites·19 claims
- 0389US8603991B2Individualized cancer therapySHANAHAN DAVID·Filed 2006·Granted Dec 10, 2013·11 cites·10 claims
- 0487US9382589B2Individualized cancer therapyGRADALIS INC·Filed 2013·Granted Jul 5, 2016·5 cites·20 claims
- 0586US9695422B2Furin-knockdown bi-functional RNAGRADALIS INC·Filed 2015·Granted Jul 4, 2017·3 cites·18 claims
- 0686US9157084B2Furin-knockdown bi-functional RNANEMUNAITIS JOHN J·Filed 2010·Granted Oct 13, 2015·6 cites·15 claims
- 0783US9790518B2Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccineGRADALIS INC·Filed 2015·Granted Oct 17, 2017·3 cites·11 claims
- 0883US9528991B2Individualized cancer therapyGRADALIS INC·Filed 2014·Granted Dec 27, 2016·3 cites·21 claims
- 0983US9132146B2Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccineNEMUNAITIS JOHN J·Filed 2010·Granted Sep 15, 2015·6 cites·7 claims
- 1082US9683237B2Multiple targeted RNAI for the treatment of cancersSTRIKE BIO INC·Filed 2015·Granted Jun 20, 2017·5 cites·10 claims
- 1182US8361983B2Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumorsGRADALIS INC·Filed 2010·Granted Jan 29, 2013·7 cites·34 claims
- 1281US9353373B2Bi-functional short-hairpin RNA (bi-shRNA) specific for single-nucleotide KRAS mutationsGRADALIS INC·Filed 2013·Granted May 31, 2016·7 cites·17 claims
- 1377US11400170B2Methods for treating cancersGRADALIS INC·Filed 2021·Granted Aug 2, 2022·1 cites·18 claims
- 1476US10253331B2Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccineGRADALIS INC·Filed 2017·Granted Apr 9, 2019·1 cites·20 claims
- 1562US2025003010A1Methods for treatment response to cancersGRADALIS INC·Filed 2022·Application pending·0 cites
- 1661US9914977B2Individualized cancer therapyGRADALIS INC·Filed 2016·Granted Mar 13, 2018·0 cites·14 claims
- 1760US2017175124A1Individualized cancer therapyGRADALIS INC·Filed 2016·Application pending·0 cites
- 1859US2023144927A1Methods for the treatment of viral respiratory infectionsGRADALIS INC·Filed 2022·Application pending·0 cites
- 1957US2023338284A1Methods for the treatment of lung tumorsGRADALIS INC·Filed 2023·Application pending·0 cites
- 2055US2013078279A1Furin-knockdown and gm-csf-augmented (fang) cancer vaccineNEMUNAITIS JOHN J·Filed 2012·Application pending·0 cites
- 2155US2009246196A1Combined targeted therapy for the treatment of proliferative diseaseLINBECK III LEO·Filed 2007·Application pending·0 cites
- 2252US2024189450A1Methods for treating cancersGRADALIS INC·Filed 2022·Application pending·0 cites
- 2351US9133459B2Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumorsNEMUNAITIS JOHN J·Filed 2012·Granted Sep 15, 2015·0 cites·20 claims
- 2451US2025313903A1Neoantigen immunotherapyGRADALIS INC·Filed 2025·Application pending·0 cites
- 2550US9273300B2Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathyMAPLES PHILLIP·Filed 2008·Granted Mar 1, 2016·0 cites·14 claims
- 2647US2022151976A1Targeting lasp1, eif4a1, eif4b and cxc4 with modulators and combinations thereof for cancer therapyUNIV TOLEDO·Filed 2020·Application pending·0 cites
- 2747US2013064881A1Compositions and methods for treating prostate cancerNEMUNAITIS JOHN J·Filed 2012·Application pending·0 cites
- 2846US2013259925A1METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC 3 shRNAGRADALIS INC·Filed 2013·Application pending·0 cites
- 2946US2013259927A1Ewing's Sarcoma Bifunctional shRNA DesignGRADALIS INC·Filed 2013·Application pending·0 cites
- 3046US2013295160A1Antagonists of mir-196aBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 3146US2007258952A1Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNABAYLOR RES INST·Filed 2007·Application pending·0 cites
- 3245US2013259926A1BI-FUNCTIONAL shRNA TARGETING MESOTHELIN AND USES THEREOFGRADALIS INC·Filed 2013·Application pending·0 cites
- 3342US2016333351A1Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS MutationsSTRIKE BIO INC·Filed 2016·Application pending·0 cites
- 3441US2013266639A1METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNABAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 3537US2011286979A1CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)TONG ALEX W·Filed 2011·Application pending·0 cites
- 3636US2016175461A1Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathySTRIKE BIO INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John J. Nemunaitis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →